Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 24;9(3):889.
doi: 10.3390/jcm9030889.

Tc-99m TRODAT-1 SPECT is a Potential Biomarker for Restless Leg Syndrome in Patients with End-Stage

Affiliations

Tc-99m TRODAT-1 SPECT is a Potential Biomarker for Restless Leg Syndrome in Patients with End-Stage

Yi-Chou Hou et al. J Clin Med. .

Abstract

Rationales: Restless leg syndrome (RLS) is a common complication in patients with end-stage renal disease (ESRD). However, there is a lack of biomarkers linking uremic RLS to dopaminergic neurons. Previous studies demonstrated that Tc-99m TRODAT-1 SPECT was a biomarker for RLS but the correlation between the physiologic parameter was lacking.

Methods: Overall, 32 patients were enrolled in the study and divided into the following 3 groups: (1) control (n = 13), (2) ESRD without RLS (n = 8) and (3) ESRD with RLS (n = 11). All patients had a clinical diagnosis of RLS and received Tc-99m TRODAT-1 SPECT. A subgroup analysis was performed to compare differences between the control and ESRD with RLS groups. Tc-99m TRODAT-1 SPECT was performed and activities in the striatum and occipital areas were measured using manually delineated regions of interest (ROIs) by an experienced nuclear medicine radiologist who was blinded to clinical data.

Results: The total ratio of Tc-99m TRODAT SPECT was lower in the ESRD with RLS group (p = 0.046). The uptake ratio of TRODAT negatively correlated with serum parathyroid hormone (r = -0.577, p = 0.015) and ferritin (r = -0.464, p = 0.039) concentrations. However, the uptake positively correlated with the hemoglobin concentration (r = 0.531, p = 0.011). The sensitivity and specificity of the total TRODAT ratio for predicting RLS in the overall population were 95.0% and 67.7%, respectively, at a cutoff value of 0.980 (area under the curve of receiver operating characteristic curve was 0.767, p = 0.024).

Conclusion: In patients with ESRD and RLS, Tc-99m TRODAT might be a potential biomarker. Dysregulated hemoglobin, serum parathyroid hormone and serum ferritin concentrations might influence the uptake of the TRODAT ratio.

Keywords: ESRD; TRODAT-1; restless leg syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
TRODAT ratio of the control (A), end stage renal disease (ESRD) without restless leg syndrome (RLS) (B) and ESRD with RLS (C) groups.
Figure 2
Figure 2
Comparative TRODAT ratio between the control and ESRD with RLS groups.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curve for total TRODAT ratio as a predictor of RLS in the entire study population (A) and in the population including the control and ESRD with RLS groups (B).
Figure 4
Figure 4
The linear regression of the caudate nucleus (A), putamen (B) and striatum (C) of the control group and the distribution of the ESRD with RLS group according to the age and the TRODAT ratio.

References

    1. Inker L.A., Astor B.C., Fox C.H., Isakova T., Lash J.P., Peralta C.A., Kurella Tamura M., Feldman H.I. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am. J. Kidney Dis. 2014;63:713–735. doi: 10.1053/j.ajkd.2014.01.416. - DOI - PubMed
    1. Zoccali C., Vanholder R., Massy Z.A., Ortiz A., Sarafidis P., Dekker F.W., Fliser D., Fouque D., Heine G.H., Jager K.J., et al. The systemic nature of CKD. Nat. Rev. Nephrol. 2017;13:344–358. doi: 10.1038/nrneph.2017.52. - DOI - PubMed
    1. Jabbari B., Vaziri N.D. The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial. Int. 2018;22:150–160. doi: 10.1111/hdi.12587. - DOI - PubMed
    1. Allen R.P., Picchietti D.L., Garcia-Borreguero D., Ondo W.G., Walters A.S., Winkelman J.W., Zucconi M., Ferri R., Trenkwalder C., Lee H.B. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—History, rationale, description, and significance. Sleep Med. 2014;15:860–873. doi: 10.1016/j.sleep.2014.03.025. - DOI - PubMed
    1. Trenkwalder C., Allen R., Hogl B., Paulus W., Winkelmann J. Restless legs syndrome associated with major diseases: A systematic review and new concept. Neurology. 2016;86:1336–1343. doi: 10.1212/WNL.0000000000002542. - DOI - PMC - PubMed

LinkOut - more resources